Phio Pharmaceuticals
PHIO
#10279
Rank
A$18.87 M
Marketcap
A$1.71
Share price
-2.56%
Change (1 day)
-59.63%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -A$10.95 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$10.73 Million, an increase over its 2023 earnings that were of -A$16.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$10.95 Million2.07%
2024 -A$10.73 Million-33.96%
2023 -A$16.24 Million-5.7%
2022 -A$17.22 Million-13.6%
2021 -A$19.93 Million51.09%
2020 -A$13.19 Million-1.28%
2019 -A$13.36 Million21.03%
2018 -A$11.04 Million-53.1%
2017 -A$23.54 Million74.49%
2016 -A$13.49 Million-12.02%
2015 -A$15.34 Million16.17%
2014 -A$13.2 Million-57.95%
2013 -A$31.39 Million62.45%
2012 -A$19.32 Million0.87%
2011 -A$19.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.23 Million 156.26%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 2,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA